HSA
ACOR
Hussman Strategic Advisors’s Acorda Therapeutics, Inc. ACOR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-75,000
| Closed | -$1.47M | – | 281 |
|
|
2018
Q3 | $1.47M | Hold |
75,000
| – | – | 0.43% | 105 |
|
|
2018
Q2 | $2.15M | Buy |
75,000
+25,000
| +50% | +$717K | 0.58% | 74 |
|
|
2018
Q1 | $1.18M | Buy |
+50,000
| New | +$1.18M | 0.33% | 115 |
|
|
2016
Q3 | – | Sell |
-75,000
| Closed | -$1.91M | – | 218 |
|
|
2016
Q2 | $1.91M | Sell |
75,000
-175,000
| -70% | -$4.46M | 0.29% | 96 |
|
|
2016
Q1 | $6.61M | Buy |
250,000
+150,000
| +150% | +$3.97M | 0.88% | 47 |
|
|
2015
Q4 | $4.28M | Buy |
100,000
+45,000
| +82% | +$1.93M | 0.61% | 66 |
|
|
2015
Q3 | $1.46M | Sell |
55,000
-81,000
| -60% | -$2.15M | 0.18% | 128 |
|
|
2015
Q2 | $4.53M | Sell |
136,000
-74,000
| -35% | -$2.47M | 0.52% | 75 |
|
|
2015
Q1 | $6.99M | Buy |
+210,000
| New | +$6.99M | 0.73% | 53 |
|